Influenza A Antibody, nucleoprotein, clone A1 | EMD Millipore MAB8257 product information

This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.

product summary

company name :

EMD Millipore

other brands :

Oncogene Research Products, Calbiochem, Novagen, Merck, Upstate Biotechnology, Chemicon, LINCO, Novabiochem, Guava

product type :

antibody

product name :

Influenza A Antibody, nucleoprotein, clone A1

catalog :

MAB8257

quantity :

100 μg

clonality :

monoclonal

host :

mouse

conjugate :

nonconjugated

clone name :

reactivity :

Alphainfluenzavirus

application :

immunocytochemistry, blocking or activating experiments

citations: 14

Published Application/Species/Sample/Dilution	Reference
blocking or activating experiments; Alphainfluenzavirus; 1:2000; fig 4	Nachbagauer R, Choi A, Izikson R, Cox M, Palese P, Krammer F. Age Dependence and Isotype Specificity of Influenza Virus Hemagglutinin Stalk-Reactive Antibodies in Humans. MBio. 2016;7:e01996-15 pubmed publisher
ELISA; Alphainfluenzavirus; tbl 2	Curtis D, Muresan P, Nachman S, Fenton T, Richardson K, Domínguez T, et al. Characterization of functional antibody and memory B-cell responses to pH1N1 monovalent vaccine in HIV-infected children and youth. PLoS ONE. 2015;10:e0118567 pubmed publisher
	Weinberg A, Curtis D, Ning M, Claypool D, Jalbert E, Patterson J, et al. Immune Responses to Circulating and Vaccine Viral Strains in HIV-Infected and Uninfected Children and Youth Who Received the 2013/2014 Quadrivalent Live-Attenuated Influenza Vaccine. Front Immunol. 2016;7:142 pubmed publisher
	Vaughan A, Brumwell A, Xi Y, Gotts J, Brownfield D, Treutlein B, et al. Lineage-negative progenitors mobilize to regenerate lung epithelium after major injury. Nature. 2015;517:621-5 pubmed publisher
	Musafia B, Oren Banaroya R, Noiman S. Designing anti-influenza aptamers: novel quantitative structure activity relationship approach gives insights into aptamer-virus interaction. PLoS ONE. 2014;9:e97696 pubmed publisher
	Price J, Jarrell J, Furman D, Kattah N, Newell E, Dekker C, et al. Characterization of influenza vaccine immunogenicity using influenza antigen microarrays. PLoS ONE. 2013;8:e64555 pubmed publisher
	Kingstad Bakke B, Brewoo J, Mai L, Kawaoka Y, Osorio J. Effects of route and coadministration of recombinant raccoon poxviruses on immune responses and protection against highly pathogenic avian influenza in mice. Vaccine. 2012;30:6402-8 pubmed publisher
	Panaampon J, Ngaosuwankul N, Suptawiwat O, Noisumdaeng P, Sangsiriwut K, Siridechadilok B, et al. A novel pathogenic mechanism of highly pathogenic avian influenza H5N1 viruses involves hemagglutinin mediated resistance to serum innate inhibitors. PLoS ONE. 2012;7:e36318 pubmed publisher
	Klimov A, Balish A, Veguilla V, Sun H, Schiffer J, Lu X, et al. Influenza virus titration, antigenic characterization, and serological methods for antibody detection. Methods Mol Biol. 2012;865:25-51 pubmed publisher
	Wagner R, Göpfert C, Hammann J, Neumann B, Wood J, Newman R, et al. Enhancing the reproducibility of serological methods used to evaluate immunogenicity of pandemic H1N1 influenza vaccines-an effective EU regulatory approach. Vaccine. 2012;30:4113-22 pubmed publisher
	Kao C, Chan T, Tsai C, Chu K, Chuang S, Lee C, et al. Emerged HA and NA mutants of the pandemic influenza H1N1 viruses with increasing epidemiological significance in Taipei and Kaohsiung, Taiwan, 2009-10. PLoS ONE. 2012;7:e31162 pubmed publisher
	Long J, Bushnell R, Tobin J, Pan K, Deem M, Nara P, et al. Evolution of H3N2 influenza virus in a guinea pig model. PLoS ONE. 2011;6:e20130 pubmed publisher
	Sullivan H, Blitvich B, VanDalen K, Bentler K, Franklin A, Root J. Evaluation of an epitope-blocking enzyme-linked immunosorbent assay for the detection of antibodies to influenza A virus in domestic and wild avian and mammalian species. J Virol Methods. 2009;161:141-6 pubmed publisher
	Leyva Grado V, Churchill L, Wu M, Williams T, Taishi P, Majde J, et al. Influenza virus- and cytokine-immunoreactive cells in the murine olfactory and central autonomic nervous systems before and after illness onset. J Neuroimmunol. 2009;211:73-83 pubmed publisher

product information

Catalog Number :

MAB8257

Subcategory :

Infectious Diseases

Product Name :

Anti-Influenza A Antibody, nucleoprotein, clone A1

Product Type :

Antibodies

Clonality :

Monoclonal Antibody

Host Name :

Mouse

Antigen :

Influenza A

Clone :

Conjugate :

Purified

Isotype :

IgG2a

Product Description :

Anti-Influenza A Antibody, nucleoprotein, clone A1

Cross Reactivity :

Human

Immunogen :

Influenza A

Specificity :

Specific for the Influenza A nucleoprotein. Has stronger binding with N1-type Flu A. No cross reactivity seen to influenza B or other respiratory viruses. Shown to react with Avian H5N1 strain. No reactivity seen to influenza B or other respiratory viruses.

Package Size :

100 μg

Uses :

Immunofluorescence

Storage :

Maintain for 1 year at 2–8°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.